NCT03679221View on ClinicalTrials.gov

Motoric Cognitive Risk and Depression

Active, not recruitingOBSERVATIONAL
Enrollment

30,000

Participants

Timeline

Start Date

July 24, 2019

Primary Completion Date

October 31, 2024

Study Completion Date

December 1, 2025

Conditions
DepressionGeriatricsNeurocognitive Disorders
Interventions
OTHER

Data collection

telephone interview questionnaire, in-home face-to-face interview, and data from the Collection Site

Trial Locations (1)

H3T 1E2

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Jewish General Hospital

OTHER

NCT03679221 - Motoric Cognitive Risk and Depression | Biotech Hunter | Biotech Hunter